SEC 13F Intelligence

Managers / Q2 2023 · view latest →

Newtyn Management, LLC

CIK 0001569241 · 60 EAST 42ND STREET, 12TH FLOOR, NEW YORK, NY, 10165 · 212-446-2465

Reported Value
$423M
Q2 2023
Positions
46
Filings on Record
30
2019–present window
Filed
Aug 14, 2023
original filing

Summary

Newtyn Management, LLC reported $423M in U.S.-listed holdings across 46 positions for Q2 2023.

Its largest position, 0J7Q, represents 13.4% of the portfolio.

Compared with Q1 2023, the fund opened 3 new positions and exited 37.

Portfolio Metrics

Turnover
+16.7%
vs prior filed quarter
Top-10 Concentration
+66.3%
share of reported value
Largest Position
+13.4%
Iac
New / Exited
3 / 37
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $511MQ4 ’18Q1 ’19: $529MQ2 ’19: $774MQ3 ’19: $1.1BQ4 ’19: $1.1BQ4 ’19Q1 ’20: $290MQ2 ’20: $273MQ3 ’20: $413MQ4 ’20: $434MQ4 ’20Q1 ’21: $370MQ2 ’21: $361MQ3 ’21: $375MQ4 ’21: $377MQ4 ’21Q1 ’22: $418MQ2 ’22: $528MQ3 ’22: $455MQ4 ’22: $485MQ4 ’22Q1 ’23: $509MQ2 ’23: $423MQ3 ’23: $405MQ4 ’23: $509MQ4 ’23Q1 ’24: $502MQ2 ’24: $533MQ3 ’24: $651MQ4 ’24: $574MQ4 ’24Q1 ’25: $632MQ2 ’25: $660MQ3 ’25: $817MQ4 ’25: $952MQ4 ’25Q1 ’26: $936Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 76.6%Other: 11.9%REIT: 7.6%ADR: 2.6%US DOMESTIC: 1.3%Other: 0.0%
  • Common Stock · 76.6% · $324M
  • Other · 11.9% · $50M
  • REIT · 7.6% · $32M
  • ADR · 2.6% · $11M
  • US DOMESTIC · 1.3% · $5M
  • Other · 0.0% · $19,230

Quarter-over-Quarter Changes full breakdown →

vs Q1 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GTXGARRETT MOTION INCNEW+1.48M1.48M+$11M$11M
PRTKEURPARATEK PHARMACEUTICALS INCNEW+764.3K764.3K+$2M$2M
AVIRATEA PHARMACEUTICALS INCNEW+89.2K89.2K+$333,597$333,597
GARRETT MOTION INCSOLD OUT−1.69M0−$15M$0
ADIENT PLCSOLD OUT−345.0K0−$14M$0
CUBICUSTOMERS BANCORP INCSOLD OUT−625.0K0−$12M$0
BCORUSDAVANTAX INCSOLD OUT−400.0K0−$11M$0
SAFESAFEHOLD INCSOLD OUT−339.3K0−$10M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2023

45 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
10J7QIAC INChistory →COM NEW13.35%$57M900.0K
2CNNECANNAE HLDGS INChistory →COM9.60%$41M2.01M
3GIIIG III APPAREL GROUP LTDhistory →COM7.49%$32M1.65M
4PARPAR TECHNOLOGY CORPhistory →COM7.00%$30M900.0K
5ARDAGH METAL PACKAGING S ASHS6.22%$26M7.00M
6MACKEURMERRIMACK PHARMACEUTICALS INhistory →COM NEW5.44%$23M1.87M
7SPBSPECTRUM BRANDS HLDGS INC NEhistory →COM4.61%$20M249.9K
8VTOLBRISTOW GROUP INChistory →COM4.58%$19M674.3K
9CIOCITY OFFICE REIT INChistory →COM4.03%$17M3.06M
10THERAVANCE BIOPHARMA INCCOM4.01%$17M1.64M
11ONLORION OFFICE REIT INChistory →COM3.58%$15M2.29M
12MBIMBIA INChistory →COM2.85%$12M1.40M
13GTXGARRETT MOTION INChistory →COM2.65%$11M1.48M
14GALAPAGOS NVSPON ADR2.59%$11M270.0K
15FETFORUM ENERGY TECHNOLOGIES INNOTE 9.000% 8/0 · COM2.37%$10M5.66M
16PHATPHATHOM PHARMACEUTICALS INChistory →COM2.31%$10M683.6K
17TSVT*2SEVENTY BIO INChistory →COMMON STOCK1.76%$7M737.7K
18NODKNI HLDGS INChistory →COM1.61%$7M460.0K
19KODKODIAK SCIENCES INChistory →COM1.61%$7M989.7K
20TILLYS INCCL A1.32%$6M800.0K
21DXLGDESTINATION XL GROUP INChistory →COM1.27%$5M1.10M
22STHOSTAR HLDGShistory →SHS BEN INT1.12%$5M324.5K
23PCGPG&E CORPhistory →COM1.10%$5M268.9K
24ASTLALGOMA STL GROUP INCCOM0.99%$4M590.9K
25ETNBGBP89BIO INCCOM0.90%$4M200.0K
26CYTEIR THERAPEUTICS INCCOM0.83%$4M1.36M
27PFSWUSDPFSWEB INCCOM NEW0.80%$3M746.4K
28AMPYAMPLIFY ENERGY CORP NEWCOM0.63%$3M393.2K
29SENSEI BIOTHERAPEUTICS INCCOM0.49%$2M1.83M
30WAVE LIFE SCIENCES LTDSHS0.43%$2M500.0K
31PRTKEURPARATEK PHARMACEUTICALS INCCOM0.40%$2M764.3K
32ADVMCHFADVERUM BIOTECHNOLOGIES INCCOM0.38%$2M1.00M
33OLMAOLEMA PHARMACEUTICALS INCCOM0.37%$2M175.0K
34BOLT1EURBOLT BIOTHERAPEUTICS INCCOM0.30%$1M1.00M
35BDTXBLACK DIAMOND THERAPEUTICS ICOM0.24%$1M200.0K
36ALIGOS THERAPEUTICS INCCOM0.21%$873,900900.0K
37DECIBEL THERAPEUTICS INCCOM0.18%$770,000200.0K
38ABIOEURARCA BIOPHARMA INCCOM0.15%$635,796313.2K
39AVIRATEA PHARMACEUTICALS INCCOM0.08%$333,59789.2K
40LWLAMB WESTON HLDGS INCCOM0.06%$247,9472.2K
41GBTGGLOBAL BUSINESS TRAVEL GROUPCOM CL A0.05%$223,57330.9K
42BRILLIANT ACQUISITION CORPRIGHT 99/99/99990.02%$63,809457.4K
43ARISZ ACQUISITION CORPRIGHT 99/99/99990.01%$22,200250.0K
44LEAFLY HOLDINGS INC*W EXP 02/04/2020.00%$19,230634.6K
45VIVEON HEALTH ACQUISITION CORIGHT 12/31/20250.00%$14,325250.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$936M33May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$952M33Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$817M33Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$660M34Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$632M31May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$574M33Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$651M40Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$533M40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$502M40May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$509M48Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$405M46Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$423M46Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$509M80May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$485M71Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$455M80Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$528M84Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$418M39May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$377M35Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$375M37Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$361M90Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$370M102May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$434M55Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$413M53Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$273M46Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$290M50May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B46Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.1B40Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$774M32Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$529M32May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$511M38Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.